Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.

Kim WY, Whang YE, Pruthi RS, Baggstrom MQ, Rathmell WK, Rosenman JG, Wallen EM, Goyal LK, Grigson G, Watkins C, Godley PA
Urol Oncol. 2011 29 (6): 608-13

PMID: 20022268 · DOI:10.1016/j.urolonc.2009.09.012

MeSH Terms (19)

Adenocarcinoma Aged Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Disease Progression Docetaxel Estramustine Humans Male Middle Aged Neoadjuvant Therapy Neoplasm Grading Neoplasm Staging Prostate-Specific Antigen Prostatectomy Prostatic Neoplasms Radiotherapy Taxoids Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links